Innovations in early disease detection are poised to rapidly change health care. AI is already being integrated into the early cancer detection process - and early Alzheimer's tests may be reshaping ...
Biomarkers (a shortened term for biological markers) are measurable characteristics of a certain biological condition or response to a medical or environmental exposure. Some biomarkers, such as blood ...
GlobalData on MSN
The slow march of clinical biomarkers to become surrogate endpoints
Ann Mongan, director of translational research at BMS, outlines how biomarkers hold pivotal roles in clinical trials.
Validated biomarkers will help physicians identify patient subgroups that will benefit most from specific treatment ...
Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...
Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
While biomarkers have transformed Alzheimer’s research, much work remains to be done to develop these important tools for other neurodegenerative diseases, not to mention for the concurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results